2021
DOI: 10.1039/d1ra01480c
|View full text |Cite
|
Sign up to set email alerts
|

Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs – biological activities and SAR studies

Abstract: This review provides critical insights into the biological activities and Structure–Activity Relationship (SAR) studies of tetrahydroisoquinoline (THIQ) analogs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
43
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 60 publications
(44 citation statements)
references
References 106 publications
0
43
0
1
Order By: Relevance
“…According to general procedure V, catalyst RhCl(PPh 3 ) 3 (10 mol%), from 54 mg (0.09 mmol) of (S, S)-6c, 34 mg of (S,S)-9c were obtained as a colourless oil (63% yield); [α] 25 D = +55.1 (c 1.0, CHCl 3 ); 1 H NMR (300 MHz, CDCl 3 ): δ ( ppm) 7.70 (d,J = 8.3 Hz,4H), 7.24 (d, J = 8.0 Hz, 4H), 6.90 (s, 2H), 4.60 (d,J = 16.7 Hz,2H),4.33 (d,J = 16.7 Hz,2H),2H),2.98 (dd,J = 15.7,5.8 Hz,2H),2.71 (d,J = 16.3 Hz,2H), 2.39 (s, 6H), 0.90-0.78 (m, 2H), 0.46-0.39 (m, 4H), 0.36-0.29 (m, 2H), 0.27-0.21 (m, 2H); 13 C NMR (75 MHz, CDCl 3 ): δ ( ppm) 143. 2,137.8,130.5,129.6 (2 × CH),128.2,127.8,127.1 (2 × CH),56.5,40.7,33.3,21.5,12.7,4.5,4.3 (3S,8S)-3,8-Di(thiophen-3-yl)-2,9-ditosyl-1,2,3,4,7,8,9,10-octahydro-2,9-phenanthroline [(S,S)-9d]. According to general procedure V, catalyst RhCl(PPh 3 ) 3 (10 mol%), from 67 mg (0.10 mmol) of (S,S)-6d, 40 mg of (S,S)-9d were obtained as a colourless oil (60% yield); [α] 25 D = +20.7 (c 1.0, CHCl 3 ); 1 H NMR (300 MHz, CDCl 3 ): δ ( ppm) 7.57 (d,J = 8.3 Hz,4H),6H),6.90 (s,2H),4H),5.47 (d,J = 5.6 Hz,2H), 4.50 (d,J = 16.8 Hz,2H),3.88 (d,J = 16.8 Hz,2H),3.16 (dd,J =...…”
Section: -Methyl-n-(4-((4-methyl-n-((s)mentioning
confidence: 99%
See 2 more Smart Citations
“…According to general procedure V, catalyst RhCl(PPh 3 ) 3 (10 mol%), from 54 mg (0.09 mmol) of (S, S)-6c, 34 mg of (S,S)-9c were obtained as a colourless oil (63% yield); [α] 25 D = +55.1 (c 1.0, CHCl 3 ); 1 H NMR (300 MHz, CDCl 3 ): δ ( ppm) 7.70 (d,J = 8.3 Hz,4H), 7.24 (d, J = 8.0 Hz, 4H), 6.90 (s, 2H), 4.60 (d,J = 16.7 Hz,2H),4.33 (d,J = 16.7 Hz,2H),2H),2.98 (dd,J = 15.7,5.8 Hz,2H),2.71 (d,J = 16.3 Hz,2H), 2.39 (s, 6H), 0.90-0.78 (m, 2H), 0.46-0.39 (m, 4H), 0.36-0.29 (m, 2H), 0.27-0.21 (m, 2H); 13 C NMR (75 MHz, CDCl 3 ): δ ( ppm) 143. 2,137.8,130.5,129.6 (2 × CH),128.2,127.8,127.1 (2 × CH),56.5,40.7,33.3,21.5,12.7,4.5,4.3 (3S,8S)-3,8-Di(thiophen-3-yl)-2,9-ditosyl-1,2,3,4,7,8,9,10-octahydro-2,9-phenanthroline [(S,S)-9d]. According to general procedure V, catalyst RhCl(PPh 3 ) 3 (10 mol%), from 67 mg (0.10 mmol) of (S,S)-6d, 40 mg of (S,S)-9d were obtained as a colourless oil (60% yield); [α] 25 D = +20.7 (c 1.0, CHCl 3 ); 1 H NMR (300 MHz, CDCl 3 ): δ ( ppm) 7.57 (d,J = 8.3 Hz,4H),6H),6.90 (s,2H),4H),5.47 (d,J = 5.6 Hz,2H), 4.50 (d,J = 16.8 Hz,2H),3.88 (d,J = 16.8 Hz,2H),3.16 (dd,J =...…”
Section: -Methyl-n-(4-((4-methyl-n-((s)mentioning
confidence: 99%
“…M.p. 69-71 °C; [α] 25 D = +37.7 (c 1.0, CHCl 3 ); 1 H NMR (300 MHz, CDCl 3 ): δ ( ppm) 7.60 (d,J = 8.3 Hz,4H),7.18 (d,J = 8.0 Hz,4H),4.19 (d,J = 17.7 Hz,2H),3.97 (d,J = 17.7 Hz,2H),2H), 3.00 (d,J = 17.1 Hz,2H),2.62 (d,J = 17.1,6.4 Hz,2H), 2.37 (s, 6H), 1.60-1.52 (m, 2H), 0.92 (d, J = 6.6 Hz, 6H), 0.91 (d, J = 6.6 Hz, 6H); 13 C NMR (75 MHz, CDCl 3 ): δ ( ppm) 143.5,137.7,132.4,129.6 (2 × CH),129.1,127.3,126.9 (2 × CH),57.4,39.9,32.0,28.6,21.5,20.0,19.9 ,2,3,4,7,8,9,. According to general procedure V, catalyst [RhCl(CO 2 )] 2 (15 mol%), from 42 mg (0.06 mmol) of (S,S)-7g, 33 mg of (S,S)-9l were obtained as a white solid (79% yield).…”
Section: -Methyl-n-(4-((4-methyl-n-((s)mentioning
confidence: 99%
See 1 more Smart Citation
“…We aimed to apply a similar amine oxidation‐imine addition sequence to functionalize 1,2,3,4‐tetrahydroisoquinolines (THIQs) which are prominent scaffolds in medicinal chemistry and in commercial drugs, e. g. quinapril, solifenacin, lifitegrast [33,34] . They are also abundant in nature.…”
Section: Introductionmentioning
confidence: 99%
“…Both THBCs and THIQs are appealing architectures, representing natural and synthetic products with diverse array of biological activities (Figure 1). [9][10][11][12] Besides being molecules of pharmacological interest, [13][14][15][16][17][18][19] these heterocycles have been latently explored in several synthetic transformations, such as oxidative rearrangement, ring-opening and CÀ H functionalization. [20][21] Thus, in its synthetic domain, several variations of PSR were devised to prepare THBCs and THIQs.…”
Section: Introductionmentioning
confidence: 99%